371 related articles for article (PubMed ID: 30017901)
21. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
Maggi M; Filippi S; Vignozzi L; Rastrelli G
Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
[TBL] [Abstract][Full Text] [Related]
22. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
23. The effect of physiotherapy in addition to testosterone replacement therapy on the efficiency of the motor system in men with hypogonadism.
Bacevičienė R; Valonytė L; Ceponis J
Medicina (Kaunas); 2013; 49(2):71-7. PubMed ID: 23888342
[TBL] [Abstract][Full Text] [Related]
24. An updated systematic review and meta-analysis of the effects of testosterone replacement therapy on erectile function and prostate.
Xu Z; Chen X; Zhou H; Ren C; Wang Q; Pan Y; Liu L; Liu X
Front Endocrinol (Lausanne); 2024; 15():1335146. PubMed ID: 38344665
[TBL] [Abstract][Full Text] [Related]
25. Update in testosterone therapy for men.
Corona G; Rastrelli G; Forti G; Maggi M
J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement therapy.
Barbonetti A; D'Andrea S; Francavilla S
Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
[TBL] [Abstract][Full Text] [Related]
28. Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels.
Zhang X; Zhong Y; Saad F; Haider KS; Haider A; Clendenin AG; Xu X
Aging Male; 2020 Jun; 23(2):112-118. PubMed ID: 30857458
[No Abstract] [Full Text] [Related]
29. Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
Mangolim AS; Brito LAR; Nunes-Nogueira VDS
Eur J Endocrinol; 2021 Dec; 186(1):123-135. PubMed ID: 34738915
[TBL] [Abstract][Full Text] [Related]
30. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
31. The association of hypogonadism with depression and its treatments.
Indirli R; Lanzi V; Arosio M; Mantovani G; Ferrante E
Front Endocrinol (Lausanne); 2023; 14():1198437. PubMed ID: 37635965
[TBL] [Abstract][Full Text] [Related]
32. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
[TBL] [Abstract][Full Text] [Related]
33. Hormone Replacement Therapy and Opioid Tapering for Opioid-Induced Hypogonadism Among Patients with Chronic Noncancer Pain: A Systematic Review.
AminiLari M; Manjoo P; Craigie S; Couban R; Wang L; Busse JW
Pain Med; 2019 Feb; 20(2):301-313. PubMed ID: 29727002
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.
Pencina KM; Travison TG; Artz AS; Lincoff AM; Nissen SE; Flevaris P; Chan A; Li X; Diegel SA; Wannemuehler K; Bhasin S
JAMA Netw Open; 2023 Oct; 6(10):e2340030. PubMed ID: 37889486
[TBL] [Abstract][Full Text] [Related]
35. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study.
Corona G; Vena W; Pizzocaro A; Giagulli VA; Francomano D; Rastrelli G; Mazziotti G; Aversa A; Isidori AM; Pivonello R; Vignozzi L; Mannucci E; Maggi M; Ferlin A
J Endocrinol Invest; 2022 May; 45(5):911-926. PubMed ID: 35041193
[TBL] [Abstract][Full Text] [Related]
36. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
38. Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden.
Arver S; Luong B; Fraschke A; Ghatnekar O; Stanisic S; Gultyev D; Müller E
J Sex Med; 2014 Jan; 11(1):262-72. PubMed ID: 23937088
[TBL] [Abstract][Full Text] [Related]
39. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population.
Zhang XW; Liu ZH; Hu XW; Yuan YQ; Bai WJ; Wang XF; Shen H; Zhao YP
Chin Med J (Engl); 2012 Nov; 125(21):3806-10. PubMed ID: 23106878
[TBL] [Abstract][Full Text] [Related]
40. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
Brunton SA; Sadovsky R
J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
